CompoAtlas

macérat mère- gemmothérapie-tilleul

Food supplement declared in France, declaration No 2023-2-501, decision dated 9 February 2023

macérat mère- gemmothérapie-tilleul, from amélie Grange, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Tilia platyphyllos 1 ml per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
amélie Grange
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Autre : gouttes
Daily dose
1 ml
Directions for use
5à 20 gouttes par jour en 1 à 3 prisesdans un fond de verre d'eau en dehors des repas
Not recommended (according to the manufacturer)
Breastfeeding women, Young children (aged 1 to 3), Pregnant women

Declaration 269639, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Tilia platyphyllos Scop.Feuille (bourgeon)Macérât hydroglycériné1 ml

Additives

E422

Other ingredients

Alcool, eau de source

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Demander l'avis de votre médecin.Déconseillé aux enfants en bas âge, aux femmes enceintes et allaitantes.Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Ne peut pas se substituer à une alimentation équilibrée. Agiter avant emploi

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Tilia platyphyllos Scop.
    Read the warning, when it applies and the studies cited

    Linden - TILIA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).

    Sources cited by Health Canada (2)
    • De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “macérat mère- gemmothérapie-tilleul: composition and regulation”, https://compoatlas.com/en/supplements/products/269639-macerat-mere-gemmotherapie-tilleul, updated 15 November 2026.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line